Nuclear factor Erythroid 2-related factor (Nrf2): A potential therapeutic target for oral cancer - Molecular insights
Saved in:
Main Authors: | Kaviyarasi Renu, Vishnu Priya Veeraraghavan, Abilash Valsala Gopalakrishnan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | Oral Oncology Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024001766 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nuclear Factor Erythroid 2-Related Factor 2 Intervenes the Release of Neutrophil Extracellular Traps during Lipopolysaccharide-Induced Acute Lung Injury in Mice
by: Junying Lu, et al.
Published: (2024-01-01) -
Emerging therapeutic targets in oral squamous cell carcinoma: Insights from genetic alterations
by: Santosh R. Patil, et al.
Published: (2024-06-01) -
Nanoengineered chemotherapy - A novel therapeutic strategy in oral cancer
by: Gayathri Rengasamy, et al.
Published: (2024-06-01) -
Lipin-1: Is a promising therapeutic candidate for head and neck cancer
by: Kaviyarasi Renu
Published: (2024-06-01) -
Disruption of erythroid nuclear opening and histone release in myelodysplastic syndromes
by: Baobing Zhao, et al.
Published: (2019-03-01)